Antony Loebel

Antony Loebel

No más puestos en curso

Fortuna: 476 181 $ al 31/08/2026

66 años
Health Technology
Consumer Services
Finance

Perfil

Antony Loebel is currently Director at Pharmaceutical Research & Manufacturers of America, Director at Sunovion Pharmaceuticals Europe Ltd. since 2019, Director at HighCape Capital Acquisition Corp.
II, Assistant Professor at New York University School of Medicine, Advisor at HighCape Partners Management LLC, and Chief Medical Officer at Seaport Therapeutics, Inc. since 2024.
Former positions include Director at Pfizer Inc. from 2006 to 2007, Director, Chief Medical Officer & Executive VP at Sumitomo Pharma America, Inc. from 2007 to 2019, Director at Massachusetts Biotechnology Council, and Independent Director at HighCape Capital Acquisition Corp.
from 2020 to 2021.
Education includes undergraduate studies at the University of Washington and a doctorate from UW Medicine.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
0,04 %
04/05/2026 20.109 ( 0,04 % ) 476 181 $ 31/08/2026

Cargos activos de Antony Loebel

EmpresasCargoInicio
Director/Miembro de la Junta -
Director/Miembro de la Junta -
Corporate Officer/Principal -
Director/Miembro de la Junta 01/04/2019
Consultor / Asesor -

Antiguos cargos conocidos de Antony Loebel.

EmpresasCargoFin
HIGE CAPI Director/Miembro de la Junta 10/06/2021
PFIZER INC. Director/Miembro de la Junta 01/01/2007
Director/Miembro de la Junta -
Director Ejecutivo -
Ver el detalle de la experiencia de Antony Loebel.

Formación de Antony Loebel.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

60

Relaciones de 1er grado

11

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas11

Health Technology

Health Technology

Consumer Services

Health Technology

Commercial Services

Consumer Services

Consumer Services

Finance

Health Technology

Finance

Finance